Understanding metabolism, generating returns: Vidac Pharma, Roche, AstraZeneca
In research into new drugs to combat diseases, there's a consensus: the holy grail is unlikely to be found. It's gradual improvements and combination therapies that promise progress in complex diseases such as cancer. Cell metabolism is considered a promising approach, for example, in cancer – if metabolism stops, the cancer cell dies. We present current approaches and also cover a biotechnology company dedicated entirely to cell metabolism. Read the full article...
© 2025 Kapitalsteigerungen.de
Solar industry on the brink of a mega comeback?
For a long time, solar stocks were considered darlings of the stock market, but then came a sharp crash: interest rate shocks, overcapacities in China, and a price collapse that put even market leaders like SMA Solar, Enphase Energy, and SolarEdge under massive pressure. Many investors have long since turned their backs on the industry. But this could be precisely the opportunity now!
The combination of AI explosion and energy transition brings the industry back into the spotlight:
- Data centers consume megawatts – solar power offers the cheapest price per kilowatt hour
- Modern modules deliver efficiencies like nuclear power plants
- hina curbs price dumping & massively pushes expansion
This offer is only valid for a short time – so don’t hesitate, secure it now!
nachrichten-aktien-europa
